
201 - 500 employees
Founded 2016
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Deciphera Pharmaceuticals is a biotechnology company dedicated to defeating cancer by developing innovative kinase inhibitors to improve patient outcomes. The company focuses on designing switch-control kinase inhibitors to address mechanisms of tumor and drug resistance, aiming to enhance treatment responses for patients with cancer. Deciphera has a diverse pipeline of drug candidates, including ripretinib and vimseltinib, and is committed to making a significant impact on the lives of cancer patients. As of June 2024, Deciphera is a wholly-owned subsidiary of ONO Pharma and continues to work on improving human health through its scientific innovations and patient-centric approach.
🔥 1 minute ago
🍂 Massachusetts – Remote
💵 $335k - $460k / year
⏰ Full Time
🔴 Lead
👔 Vice President
🦅 H1B Visa Sponsor
👻 Ghost score 0%
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2016
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Deciphera Pharmaceuticals is a biotechnology company dedicated to defeating cancer by developing innovative kinase inhibitors to improve patient outcomes. The company focuses on designing switch-control kinase inhibitors to address mechanisms of tumor and drug resistance, aiming to enhance treatment responses for patients with cancer. Deciphera has a diverse pipeline of drug candidates, including ripretinib and vimseltinib, and is committed to making a significant impact on the lives of cancer patients. As of June 2024, Deciphera is a wholly-owned subsidiary of ONO Pharma and continues to work on improving human health through its scientific innovations and patient-centric approach.
• Develop and execute the global pharmacovigilance strategy in alignment with corporate objectives, regulatory requirements, and the company’s commitment to patient safety • Provide executive leadership for benefit-risk evaluation, safety governance, safety surveillance, signal management, and risk management across investigational and marketed products • Serve as a senior safety advisor to executive leadership • Represent Pharmacovigilance in governance committees, leadership forums, and interactions with health authorities • Ensure global pharmacovigilance activities are compliant, inspection-ready, scientifically rigorous, and aligned with regulatory requirements, GCP standards, and internal quality systems • Establish and evolve scalable pharmacovigilance systems, processes, quality frameworks, vendor partnerships, and operational capabilities • Build, develop, and lead a high-performing pharmacovigilance organization • Foster a culture of scientific excellence, accountability, collaboration, and patient-focused decision making • Partner closely with Clinical Development, Regulatory Affairs, Medical Affairs, Quality, Commercial, Technical Operations, and other key functions
• MD, DO, PharmD, PhD, or equivalent advanced scientific or healthcare degree • 15+ years of progressive experience in pharmacovigilance, clinical safety, drug safety, or drug development within the biotechnology or pharmaceutical industry • 8+ years of leadership experience managing global pharmacovigilance, clinical safety, or patient safety organizations • Demonstrated experience supporting products across clinical development and commercialization • Deep understanding of global pharmacovigilance regulations, guidelines, and industry best practices, including FDA, EMA, ICH, GCP, and other applicable requirements • Experience with safety governance, benefit-risk assessment, signal detection, risk management, safety reporting, and inspection readiness • Track record of successful health authority interactions, regulatory inspections, audits, and cross-functional safety leadership • Strong strategic leadership, communication, decision-making, and stakeholder management skills • Oncology experience strongly preferred • Experience supporting small molecule therapeutics • Prior experience leading pharmacovigilance activities for commercial-stage products • Experience working in a global, outsourced operating model utilizing CROs and external pharmacovigilance vendors • Demonstrated success building, scaling, and evolving pharmacovigilance organizations, systems, and operating models • Experience supporting regulatory submissions, product launches, and post-marketing safety activities in multiple global markets • Strong business acumen with the ability to align safety strategy with corporate objectives
• Equity-based compensation • Medical insurance • Dental insurance • Vision insurance • 401(k) retirement plan with company match • Life insurance • Flexible spending account for health care and/or dependent care • Annual performance bonus • Long-term incentive plan • Generous parental leave • Family planning benefits • Opportunities for personal and professional growth
Apply Now🔥 2 minutes ago
Vice President leading enterprise communications for Circana, a provider of AI, technology, and data solutions to consumer packaged goods companies. Driving M&A, HR, change, leadership, and reputation communications.
🔥 1 hour ago
Regional Vice President selling qualified retirement plans through financial intermediaries. Managing prospects, advisor relationships, and territory sales for Transamerica.
🔥 1 hour ago
VP Biostatistics leading statistical strategy, clinical-trial analysis, and regulatory submissions for BioCryst’s rare-disease therapeutics. Managing biostatistics staff, CROs, and global agency interactions.
🇺🇸 United States – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Vice President
🔥 2 hours ago
Strategic enterprise sales leader selling Included Health’s integrated virtual care and navigation solutions to large employers. Building executive relationships, closing complex healthcare-benefits deals, and expanding enterprise accounts.
🔥 2 hours ago
VP leading AI data-center platform strategy at Submer, which delivers high-density liquid-cooled infrastructure. Shaping solutions, pricing, industrialization, and global deployment.